Ignite Creation Date:
2025-12-26 @ 2:40 PM
Ignite Modification Date:
2025-12-26 @ 2:40 PM
Study NCT ID:
NCT04656106
Status:
COMPLETED
Last Update Posted:
2021-09-28
First Post:
2020-11-30
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study Investigating the Clinical Parameters Associated With the Use of Ryzodeg® (Insulin Degludec/Insulin Aspart) in a Real-world Adult Population With Type 2 Diabetes in South Korea
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-27
Start Date Type:
ACTUAL
Primary Completion Date:
2021-07-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-07-01
Completion Date Type:
ACTUAL
First Submit Date:
2020-11-30
First Submit QC Date:
None
Study First Post Date:
2020-12-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-27
Last Update Post Date:
2021-09-28
Last Update Post Date Type:
ACTUAL